Chapter 15: Local Anesthetics — Module 4: Toxicity, Adverse Effects, and Special Populations Tier: Core Concepts — Foundational Knowledge (22 questions)
1. A clinician performing a nerve block must understand the most feared complication of local anesthetic use. The abbreviation LAST is used throughout regional anesthesia practice. What does LAST describe?
A) A localized skin reaction occurring at the site where the local anesthetic is injected
B) Local anesthetic systemic toxicity — the syndrome that results when the drug reaches blood levels high enough to poison the central nervous system and heart
C) A failure of the local anesthetic to produce adequate numbness, requiring a repeat injection
D) An allergic reaction to the preservative contained in multidose anesthetic vials
E) The expected sensation of temporary nerve blockade that resolves as the drug wears off
ANSWER: B
Rationale:
Local anesthetic systemic toxicity (LAST) is the term for the clinical syndrome that develops when the plasma concentration of a local anesthetic rises to a level sufficient to produce toxic effects on the two most sensitive organ systems — the central nervous system and the cardiovascular system. It is the most feared and potentially lethal complication of regional anesthesia and any procedure using local anesthetics, and recognizing it is a core competency for every clinician who injects these drugs.
Option A: Option A is incorrect because LAST is by definition a systemic event driven by blood levels, not a local skin reaction confined to the injection site.
Option C: Option C is incorrect because failure to achieve numbness is a problem of inadequate effect, the opposite of the excessive systemic effect that defines LAST.
Option D: Option D is incorrect because preservative allergy is an immunologic reaction, a separate adverse-effect category from the dose-dependent systemic toxicity that LAST denotes.
Option E: Option E is incorrect because it describes the normal, intended, self-limited action of the drug rather than a toxic complication.
2. A resident learning regional anesthesia asks how local anesthetic ends up at toxic levels in the blood in the first place. Which of the following is the most common cause of LAST?
A) Slow absorption of an appropriately sized dose from a poorly vascular tissue site
B) An allergic reaction that releases the drug from tissue stores into the circulation
C) Renal failure preventing excretion of an otherwise safe dose of anesthetic
D) Unintentional injection of the anesthetic directly into a blood vessel, delivering a rapid bolus into the circulation
E) Conversion of the local anesthetic into a more toxic metabolite by liver enzymes
ANSWER: D
Rationale:
The most common cause of LAST is unintentional intravascular injection — depositing all or part of an intended perineural or epidural dose directly into a blood vessel, which produces a rapid bolus of drug into the systemic circulation that bypasses the normal buffering provided by gradual tissue distribution and absorption. Because the drug reaches the brain and heart quickly and at high concentration, this mechanism tends to produce sudden, dramatic toxicity. The second mechanism, absolute dose excess, produces a more gradual rise; a third, delayed accumulation, occurs during continuous infusions.
Option A: Option A is incorrect because slow absorption from a poorly vascular site is actually protective and is the principle that makes techniques such as tumescent anesthesia safe, not a cause of toxicity.
Option B: Option B is incorrect because LAST is a dose-dependent pharmacologic toxicity, not an immunologic event, and allergy does not release tissue-stored drug into the blood.
Option C: Option C is incorrect because amide local anesthetics are cleared by the liver rather than the kidney, so renal failure is not the principal driver of acute LAST.
Option E: Option E is incorrect because local anesthetic metabolites are generally less active than the parent drug, so metabolism reduces rather than creates the toxic species.
3. In most cases of evolving LAST with a typical agent such as lidocaine, which organ system shows toxic effects first, and why does this matter clinically?
A) The central nervous system shows effects first because it is more sensitive than the heart, giving early warning symptoms before cardiovascular collapse
B) The cardiovascular system shows effects first because the heart receives the largest share of cardiac output
C) The kidneys show effects first because they filter the drug before it reaches other organs
D) The respiratory muscles fail first because local anesthetics act preferentially on the diaphragm
E) The liver shows effects first because it is the site where the drug is concentrated and metabolized
ANSWER: A
Rationale:
For most local anesthetics, the central nervous system is more sensitive to toxicity than the cardiovascular system, so CNS symptoms typically appear at lower plasma concentrations and precede cardiovascular manifestations. This hierarchy is clinically valuable because the early CNS symptoms function as a built-in warning system: if recognized promptly, drug administration can be stopped before the higher concentrations needed for cardiovascular collapse are reached.
Option B: Option B is incorrect because, although the heart does receive substantial blood flow, the cardiovascular system is generally more resistant to local anesthetic toxicity than the CNS and is affected later for most agents.
Option C: Option C is incorrect because the kidneys are not a primary target of local anesthetic toxicity and do not produce the early warning signs.
Option D: Option D is incorrect because respiratory compromise in LAST results from generalized CNS depression late in the sequence, not from a selective early action on the diaphragm.
Option E: Option E is incorrect because the liver is the site of metabolism but is not the organ whose dysfunction signals early toxicity.
4. An awake patient receiving a peripheral nerve block begins to report symptoms during injection. Which set of symptoms represents the classic EARLY warning signs of local anesthetic systemic toxicity?
A) Sudden chest pain radiating to the left arm with diaphoresis
B) Gradual onset of a pruritic rash and facial swelling over several minutes
C) Numbness around the mouth, a metallic taste, ringing in the ears (tinnitus), and lightheadedness
D) High fever, neck stiffness, and photophobia
E) Painless loss of vision in one eye
ANSWER: C
Rationale:
The earliest central nervous system warning symptoms of LAST are subtle and sensory: circumoral (around the mouth) numbness, tongue paresthesias, a metallic taste, lightheadedness, tinnitus (ringing in the ears), and diplopia. These reflect the first effects of rising drug levels on the brain and are the signals that should prompt the clinician to stop injecting before progression to agitation, seizures, and ultimately CNS depression.
Option A: Option A is incorrect because chest pain radiating to the arm describes myocardial ischemia, not the early sensory prodrome of LAST.
Option B: Option B is incorrect because a pruritic rash and facial swelling describe an allergic or anaphylactic reaction, a different adverse-effect category.
Option D: Option D is incorrect because fever, neck stiffness, and photophobia describe meningitis, which is unrelated to acute anesthetic toxicity.
Option E: Option E is incorrect because painless monocular vision loss describes a vascular ocular event, not local anesthetic toxicity.
5. A patient develops cardiovascular collapse from suspected local anesthetic systemic toxicity. In addition to standard resuscitation, which specific antidote-type therapy is the cornerstone of LAST treatment?
A) Intravenous sodium bicarbonate to alkalinize the blood and trap the drug
B) High-dose naloxone to reverse the anesthetic effect
C) Activated charcoal given by nasogastric tube to bind the drug
D) Intravenous calcium gluconate to stabilize cardiac membranes
E) Intravenous lipid emulsion (Intralipid 20%), which helps remove the lipid-soluble anesthetic from the tissues where it is causing toxicity
ANSWER: E
Rationale:
Intravenous lipid emulsion (ILE) therapy — commonly Intralipid 20% — is the cornerstone of specific treatment for LAST. The most widely cited explanation is the "lipid sink" mechanism: the infused lipid creates an expanding intravascular fat phase that draws the highly lipid-soluble anesthetic (especially bupivacaine) out of the aqueous plasma and away from the heart and brain, lowering the free concentration acting on ion channels. Additional benefit may come from improved cardiac energy metabolism. Lipid emulsion should be immediately available wherever local anesthetics are used in significant quantities.
Option A: Option A is incorrect because, although hyperventilation/alkalinization is a supportive measure, bicarbonate is not the defining antidote for LAST.
Option B: Option B is incorrect because naloxone reverses opioids and has no role in local anesthetic toxicity.
Option C: Option C is incorrect because activated charcoal addresses ingested oral poisons, not a drug already injected into the circulation.
Option D: Option D is incorrect because calcium is not the specific rescue agent for LAST, even though cardiac instability is present.
6. Local anesthetics are divided into two chemical classes: esters and amides. With respect to true (immune-mediated) allergic reactions, which statement is correct?
A) Amide anesthetics cause the great majority of true allergic reactions because of their nitrogen-containing structure
B) Ester anesthetics cause true allergic reactions far more often than amides, because they are broken down into para-aminobenzoic acid (PABA), a recognized allergen
C) Both classes cause allergic reactions at exactly equal rates because they share an identical metabolic pathway
D) Neither class can ever cause a true allergic reaction because local anesthetics are not capable of triggering the immune system
E) Allergic reactions occur only when the two classes are mixed together in the same syringe
ANSWER: B
Rationale:
True type I (IgE-mediated) hypersensitivity is far more common with ester local anesthetics than with amides. Esters are metabolized to para-aminobenzoic acid (PABA), a well-recognized allergen capable of stimulating IgE production and triggering mast cell degranulation on re-exposure. Amide metabolism produces no PABA, so true amide allergy is extremely rare, and cross-reactivity between the classes is not pharmacologically plausible — which is why a patient with a convincing ester reaction can be switched to an amide.
Option A: Option A is incorrect because it reverses the actual pattern; amides are the class with very rare true allergy.
Option C: Option C is incorrect because the two classes are metabolized differently (plasma esterases for esters versus hepatic enzymes for amides) and do not share an identical pathway or equal allergy rates.
Option D: Option D is incorrect because true allergy, although uncommon, genuinely occurs, predominantly with esters.
Option E: Option E is incorrect because allergy depends on immune recognition of a specific agent, not on mixing the two classes.
7. Methemoglobinemia is a hematologic adverse effect in which hemoglobin is oxidized to a form that cannot carry oxygen. Which two local anesthetics are the classic causes of this complication?
A) Lidocaine and bupivacaine
B) Ropivacaine and mepivacaine
C) Cocaine and tetracaine
D) Benzocaine and prilocaine
E) Procaine and chloroprocaine
ANSWER: D
Rationale:
Benzocaine and prilocaine are the local anesthetics most strongly associated with methemoglobinemia, a state in which oxidizing agents convert functional oxyhemoglobin (iron in the Fe2+ state) to methemoglobin (Fe3+), which cannot bind or transport oxygen. Benzocaine, common in topical sprays and throat preparations, is a particularly frequent culprit. Recognizing these two agents lets the clinician anticipate the risk, especially in neonates whose fetal hemoglobin is more easily oxidized.
Option A: Option A is incorrect because lidocaine and bupivacaine are not typical causes of clinically significant methemoglobinemia at standard doses.
Option B: Option B is incorrect because ropivacaine and mepivacaine are not the recognized offending agents.
Option C: Option C is incorrect because, while these agents have other notable effects, they are not the classic methemoglobinemia-causing pair.
Option E: Option E is incorrect because procaine and chloroprocaine are not the characteristic causes of this complication.
8. A patient develops significant methemoglobinemia after a topical anesthetic. What is the first-line treatment?
A) Methylene blue given intravenously, which accelerates the enzymatic conversion of methemoglobin back to normal hemoglobin
B) Intravenous lipid emulsion to bind the oxidized hemoglobin
C) Immediate exchange transfusion as the routine first step in all cases
D) High-flow supplemental oxygen alone, which fully corrects the abnormality
E) Intravenous epinephrine to raise the blood pressure and reverse the cyanosis
ANSWER: A
Rationale:
The first-line treatment for clinically significant methemoglobinemia is methylene blue given intravenously (typically 1 to 2 mg/kg over several minutes). Methylene blue is reduced to leukomethylene blue, which then donates electrons through the NADPH-dependent reductase system, greatly accelerating the conversion of methemoglobin (Fe3+) back to functional hemoglobin (Fe2+); cyanosis typically improves within 15 to 30 minutes.
Option B: Option B is incorrect because lipid emulsion is the antidote for local anesthetic systemic toxicity, not for the hemoglobin oxidation of methemoglobinemia.
Option C: Option C is incorrect because exchange transfusion is reserved for severe or refractory cases or for patients in whom methylene blue is contraindicated, not as routine first-line therapy.
Option D: Option D is incorrect because the defect is the hemoglobin's inability to carry oxygen, so supplemental oxygen alone does not correct it, which is precisely why oxygen-resistant cyanosis is a clue to the diagnosis.
Option E: Option E is incorrect because epinephrine treats hemodynamic collapse and does not reduce methemoglobin back to functional hemoglobin.
9. Epinephrine is frequently added to local anesthetic solutions (for example, at a 1:200,000 concentration). With respect to systemic toxicity, what is the principal benefit of including epinephrine?
A) It increases the metabolism of the local anesthetic in the liver
B) It directly blocks the local anesthetic from binding to sodium channels
C) It causes local vasoconstriction that slows absorption of the anesthetic into the bloodstream, lowering the peak plasma concentration
D) It neutralizes the local anesthetic chemically before it can be absorbed
E) It speeds removal of the local anesthetic by the kidneys
ANSWER: C
Rationale:
Epinephrine added to a local anesthetic solution produces local vasoconstriction at the injection site. By narrowing the nearby blood vessels, it slows the rate at which the anesthetic is absorbed into the systemic circulation, which lowers the peak plasma concentration and reduces the risk of reaching toxic levels. As a secondary benefit, a sudden tachycardia after a test increment can signal accidental intravascular placement.
Option A: Option A is incorrect because epinephrine does not increase hepatic metabolism of the anesthetic; it acts on local blood flow.
Option B: Option B is incorrect because epinephrine does not block sodium channels — that is the mechanism of the local anesthetic itself.
Option D: Option D is incorrect because epinephrine does not chemically neutralize the anesthetic.
Option E: Option E is incorrect because epinephrine does not enhance renal elimination; slowed absorption, not faster excretion, is the relevant effect.
10. Two patients ultimately reach the same peak plasma concentration of local anesthetic, but one reaches it within seconds (from an accidental intravascular injection) and the other reaches it slowly over many minutes (from gradual tissue absorption). What does the difference in the RATE of rise predict?
A) The two patients will have identical toxicity because the peak concentration is the same
B) The patient with the slow rise will have more severe toxicity because the drug is present longer
C) Rate of rise is irrelevant; only the total dose injected determines toxicity
D) The slow rise is more dangerous because it bypasses the lungs entirely
E) The patient with the rapid rise will have more severe toxicity, because a fast rise overwhelms the body's buffering and leaves no time for compensation
ANSWER: E
Rationale:
The rate at which the plasma concentration rises is itself a key determinant of toxicity severity. A given peak reached rapidly — as in intravascular injection — produces more severe toxicity than the same peak reached gradually, because a fast bolus overwhelms the lung first-pass buffering that normally sequesters lipid-soluble anesthetic during distribution, and it leaves no time for compensatory physiologic responses. This is why accidental intravascular injection is sudden and dramatic, whereas dose-excess toxicity often has a slower, more recognizable prodrome.
Option A: Option A is incorrect because identical peaks do not produce identical toxicity when the rates of rise differ.
Option B: Option B is incorrect because it reverses the relationship; the rapid rise, not the slow one, is more dangerous.
Option C: Option C is incorrect because rate of rise clearly matters in addition to total dose.
Option D: Option D is incorrect because it is the rapid bolus that overwhelms the lung buffering, and the statement misattributes the danger to the slow rise.
11. For lidocaine, cardiovascular collapse occurs at plasma concentrations roughly three to four times higher than those causing CNS symptoms — a wide safety margin. How does bupivacaine differ, and why does this matter?
A) Bupivacaine has an even wider safety margin than lidocaine, so it is the safest agent for large-volume blocks
B) Bupivacaine has a narrow margin — cardiovascular toxicity occurs at concentrations only slightly above the CNS threshold — so cardiac collapse can occur with little or no warning
C) Bupivacaine causes no cardiovascular toxicity at any concentration
D) Bupivacaine affects only the CNS and spares the heart entirely
E) Bupivacaine's margin is identical to lidocaine's, so the two agents carry the same cardiac risk
ANSWER: B
Rationale:
Bupivacaine has a dangerously narrow separation between its CNS-toxic and cardiovascular-toxic concentrations: cardiovascular toxicity occurs at levels only slightly above the CNS threshold. This is clinically critical because the protective early-warning window that lidocaine provides is largely absent — cardiac events can occur simultaneously with, or even before, the CNS prodrome. Combined with bupivacaine's slow dissociation from cardiac sodium channels, this makes bupivacaine cardiac toxicity especially difficult to resuscitate.
Option A: Option A is incorrect because it reverses the truth; bupivacaine's margin is narrower, not wider, than lidocaine's.
Option C: Option C is incorrect because bupivacaine is in fact notably cardiotoxic at high concentrations.
Option D: Option D is incorrect because bupivacaine strongly affects the heart and does not spare it.
Option E: Option E is incorrect because the margins are not identical; bupivacaine carries a substantially higher cardiac risk for a given degree of CNS effect.
12. A patient who received topical benzocaine becomes cyanotic. The pulse oximeter reads about 85% and does not improve despite high-flow oxygen. Which statement best explains these findings and the correct diagnostic step?
A) The oximeter is broken and should be ignored; clinical appearance alone confirms hypoxia
B) The low reading reflects true severe hypoxemia that will respond promptly to more oxygen
C) The cyanosis is from anxiety-induced hyperventilation and needs no further testing
D) Methemoglobin confuses the standard pulse oximeter, which tends to read near 85% regardless of severity, and co-oximetry on a blood gas is needed to measure the true methemoglobin level
E) The finding indicates carbon monoxide poisoning and mandates immediate hyperbaric therapy
ANSWER: D
Rationale:
In methemoglobinemia, the standard two-wavelength pulse oximeter cannot distinguish methemoglobin from oxyhemoglobin and tends to plateau near 85% regardless of the true methemoglobin fraction; the cyanosis characteristically does not improve with supplemental oxygen because the problem is the hemoglobin's inability to carry oxygen, not a lack of inspired oxygen. Co-oximetry, available on arterial blood gas analyzers, directly measures the methemoglobin fraction and is the diagnostic test of choice.
Option A: Option A is incorrect because the oximeter is not broken; it is being predictably misled by methemoglobin, and that pattern is itself a diagnostic clue.
Option B: Option B is incorrect because the reading does not reflect ordinary hypoxemia and will not correct with more oxygen.
Option C: Option C is incorrect because true cyanosis with an oxygen-resistant low reading is not explained by anxiety and does require testing.
Option E: Option E is incorrect because, although co-oximetry also detects carboxyhemoglobin, the benzocaine exposure and classic pattern point to methemoglobinemia, not carbon monoxide poisoning.
13. Resuscitation for LAST-related cardiac arrest differs in several ways from standard cardiac arrest management. With respect to epinephrine, which modification is recommended?
A) Epinephrine should be given in reduced doses (small boluses) rather than the standard 1 mg dose, because large doses may worsen arrhythmias in a heart already poisoned by the anesthetic
B) Epinephrine should be given in much larger doses than usual to overcome the sodium channel blockade
C) Epinephrine is the single most important antidote and replaces lipid emulsion
D) Epinephrine should be avoided entirely and replaced with vasopressin in every case
E) Epinephrine dosing is unchanged from standard cardiac arrest protocols
ANSWER: A
Rationale:
In LAST-related cardiac arrest, epinephrine is recommended in reduced doses (small boluses, on the order of 10 to 100 micrograms) rather than the standard 1 mg ACLS dose. Large epinephrine doses can worsen ventricular arrhythmias in a heart whose conduction is already impaired by anesthetic-induced sodium channel blockade, and animal models show better outcomes with lipid emulsion than with high-dose epinephrine alone.
Option B: Option B is incorrect because larger-than-usual doses are specifically discouraged, being the opposite of the recommendation.
Option C: Option C is incorrect because lipid emulsion, not epinephrine, is the cornerstone antidote; epinephrine is an adjunct used cautiously.
Option D: Option D is incorrect because epinephrine is not eliminated entirely; rather, it is used in reduced doses, and it is vasopressin that is not recommended in LAST.
Option E: Option E is incorrect because the dosing is deliberately changed, not unchanged, in the LAST setting.
14. A patient with LAST has a seizure. Which class of drug is preferred for terminating the seizure, and what is the reasoning?
A) A large dose of propofol, because it is the most reliable seizure suppressant regardless of cardiac status
B) A neuromuscular blocker such as succinylcholine, because stopping the muscle movements cures the seizure
C) A benzodiazepine such as midazolam, because it controls the seizure while avoiding the additional cardiac depression that agents like propofol or thiopental can cause
D) A barbiturate such as thiopental, because it has no effect on the cardiovascular system
E) No treatment, because seizures in LAST are harmless and self-limited
ANSWER: C
Rationale:
Benzodiazepines (for example, midazolam) are preferred for terminating LAST seizures because they control seizure activity without adding the myocardial depression and negative inotropy that propofol and thiopental can cause — an important consideration when the heart may already be compromised by the anesthetic. If benzodiazepines are unavailable, small doses of propofol are acceptable while lipid emulsion is prepared.
Option A: Option A is incorrect because a large propofol dose risks worsening cardiovascular depression in a patient who may be heading toward cardiac toxicity.
Option B: Option B is incorrect because a neuromuscular blocker only stops the visible muscle activity; it does not stop the underlying cortical seizure or protect the brain.
Option D: Option D is incorrect because thiopental does depress the cardiovascular system, contrary to the claim.
Option E: Option E is incorrect because seizures are not harmless — they cause hypoxia and metabolic stress and must be treated.
15. A patient has a documented true allergic reaction to an ester local anesthetic (with confirmed sensitivity to PABA, the allergenic breakdown product of esters). The patient now needs a procedure requiring local anesthesia. What is the appropriate choice?
A) Avoid all local anesthetics permanently and proceed without any anesthesia
B) Give a higher dose of the same ester agent to overwhelm the immune response
C) Use a different ester agent, since esters do not cross-react with one another
D) Pretreat with antihistamines and give the same ester agent
E) Use an amide local anesthetic, because amides are not metabolized to PABA and do not cross-react with esters
ANSWER: E
Rationale:
A patient with a true allergy to an ester agent should receive an amide local anesthetic. Esters are metabolized to PABA, the allergen responsible for the reaction; amides produce no PABA, and cross-reactivity between the two classes is not pharmacologically plausible, so an amide is a safe substitute.
Option A: Option A is incorrect because proceeding without anesthesia is unnecessary and harmful when a safe alternative class exists.
Option B: Option B is incorrect because giving more of the offending allergen risks a more severe reaction, not tolerance.
Option C: Option C is incorrect because ester agents share the PABA metabolite and therefore do cross-react with one another, making another ester unsafe.
Option D: Option D is incorrect because antihistamine pretreatment does not reliably prevent a true IgE-mediated reaction, and continuing the offending class is the wrong strategy when an amide is available.
16. Methylene blue is the standard treatment for significant methemoglobinemia, but it is contraindicated in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency — an inherited enzyme deficiency that limits a cell's ability to generate the reducing molecule NADPH. Why is methylene blue ineffective and potentially harmful in these patients?
A) Methylene blue is broken down too quickly in G6PD deficiency to reach an effective level
B) Methylene blue requires NADPH to be converted into its active reducing form, and G6PD-deficient patients cannot generate enough NADPH, so the drug fails to work and may itself act as an oxidizing stress
C) Methylene blue causes immediate kidney failure specifically in G6PD-deficient patients
D) Methylene blue is an antibiotic that has no role in methemoglobinemia at all
E) G6PD deficiency makes methylene blue bind irreversibly to hemoglobin, worsening oxygen delivery permanently
ANSWER: B
Rationale:
Methylene blue works by being reduced (using NADPH generated through the hexose monophosphate shunt) to leukomethylene blue, which then drives the enzymatic conversion of methemoglobin back to functional hemoglobin. In G6PD deficiency, the shunt cannot generate adequate NADPH, so methylene blue cannot be activated and is ineffective; moreover, methylene blue is itself an oxidizing agent and can paradoxically worsen the situation. Alternatives such as ascorbic acid or exchange transfusion are used instead.
Option A: Option A is incorrect because the failure is due to lack of NADPH-dependent activation, not accelerated breakdown.
Option C: Option C is incorrect because the problem is failure of the reducing pathway, not a specific renal toxicity.
Option D: Option D is incorrect because methylene blue is not an antibiotic and is in fact the standard therapy in patients who are not G6PD-deficient.
Option E: Option E is incorrect because the issue is inability to activate the drug, not irreversible binding to hemoglobin.
17. Earlier questions established that the early warning signs of LAST are subjective CNS symptoms the patient reports. Consider a patient receiving a nerve block while under general anesthesia or deep sedation. How does this change the clinical picture, and what does it imply for management?
A) Sedation eliminates the risk of LAST entirely, so no special precautions are needed
B) The sedated patient will report the early symptoms even more clearly than an awake patient
C) Sedation slows drug absorption so much that LAST cannot occur during anesthesia
D) The patient cannot report the early warning symptoms, so the first sign of LAST may be a seizure or cardiovascular event with no prodrome — making prevention and vigilance the primary strategy
E) The first sign will reliably be a skin rash, which is easy to detect under anesthesia
ANSWER: D
Rationale:
The early-warning value of CNS symptoms depends on an awake patient who can report numbness, tinnitus, or a metallic taste. In a sedated or anesthetized patient those subjective symptoms cannot be communicated, so the protective prodrome is lost and the first manifestation of LAST may be a seizure or a cardiovascular event. This is exactly why prevention — careful dosing, fractionated injection, aspiration, and vigilance — becomes the primary strategy in these patients.
Option A: Option A is incorrect because sedation does not remove the risk of LAST; it removes the warning, which is more dangerous.
Option B: Option B is incorrect because a sedated patient is less able, not more able, to report symptoms.
Option C: Option C is incorrect because sedation does not meaningfully slow systemic absorption or prevent toxicity.
Option E: Option E is incorrect because a rash is an allergic sign, not the characteristic first manifestation of LAST, which is the dose-dependent CNS or cardiovascular event.
18. Tumescent anesthesia (used in liposuction) injects very large volumes of highly dilute lidocaine with epinephrine into subcutaneous fat — a poorly vascular site. Using the absorption principles from earlier questions, what is the key safety implication of this technique's pharmacokinetics?
A) Because the dilute, epinephrine-containing solution is absorbed very slowly, the peak lidocaine level may not occur until many hours later, so LAST can appear in recovery or even after the patient has gone home, requiring extended monitoring
B) Because absorption is so slow, LAST is impossible with tumescent anesthesia at any dose
C) Peak levels occur within seconds, exactly as with an intravascular injection
D) The epinephrine speeds absorption, so toxicity always appears during the procedure itself
E) The technique removes the need to track total lidocaine dose because dilution guarantees safety
ANSWER: A
Rationale:
The safety of tumescent anesthesia rests on extremely slow systemic absorption — the combination of high dilution, a poorly vascular subcutaneous site, and epinephrine-induced vasoconstriction means peak plasma lidocaine may not be reached for many hours after infiltration. The crucial implication is that LAST, if it occurs, can present late — in the recovery area or even after discharge from an outpatient facility — so monitoring must extend well beyond the procedure itself.
Option B: Option B is incorrect because LAST remains possible, particularly if the dose greatly exceeds limits or epinephrine is omitted; slow absorption reduces but does not abolish risk.
Option C: Option C is incorrect because it describes intravascular injection, the opposite of the slow tumescent profile.
Option D: Option D is incorrect because epinephrine slows absorption, and toxicity characteristically appears late rather than during the procedure.
Option E: Option E is incorrect because total dose must still be tracked; the technique uses specific weight-based limits rather than relying on dilution alone.
19. Shortly after receiving an epinephrine-containing local anesthetic, a patient develops a racing heart, tremor, and anxiety. Using what earlier questions established about both epinephrine and the early signs of LAST, how should the clinician interpret this?
A) These are definitive signs of severe LAST, and lipid emulsion should be given immediately without further assessment
B) These symptoms prove a true allergic reaction to the anesthetic
C) These symptoms (tachycardia, tremor, anxiety) are typical systemic effects of the absorbed epinephrine and must be distinguished from early LAST, whose hallmark early signs are sensory CNS symptoms such as circumoral numbness, metallic taste, and tinnitus
D) These symptoms are always meaningless and require no monitoring
E) These symptoms confirm methemoglobinemia and require methylene blue
ANSWER: C
Rationale:
Tachycardia, tremor, and anxiety are common sympathomimetic effects of systemically absorbed epinephrine and are frequently confused with early LAST. The distinction matters: the hallmark early signs of LAST are sensory CNS symptoms — circumoral numbness, metallic taste, tinnitus, lightheadedness — rather than the adrenergic picture of epinephrine effect. The clinician should recognize the epinephrine pattern while remaining vigilant and continuing to monitor, because the two can coexist.
Option A: Option A is incorrect because these adrenergic symptoms are not by themselves diagnostic of severe LAST, and reflexive lipid emulsion without assessment is inappropriate.
Option B: Option B is incorrect because tachycardia and tremor are sympathomimetic, not the urticaria/angioedema/bronchospasm pattern of true allergy.
Option D: Option D is incorrect because the symptoms are not meaningless; they warrant continued monitoring even if benign.
Option E: Option E is incorrect because these findings are not the cyanosis-and-oxygen-resistant pattern of methemoglobinemia and do not call for methylene blue.
20. Bupivacaine binds cardiac sodium channels with "fast-in, slow-out" kinetics — it enters quickly but dissociates very slowly. Combining this with the narrow safety margin and the antidote established earlier, what does this predict about resuscitation from bupivacaine cardiac toxicity?
A) Cardiac arrest from bupivacaine reverses instantly with a single defibrillation because the drug leaves the channel immediately
B) Bupivacaine toxicity needs no specific therapy beyond a brief period of chest compressions
C) Because bupivacaine leaves the channel quickly, standard short ACLS is always sufficient
D) The slow dissociation makes toxicity mild and self-correcting without intervention
E) Because the drug clears from the cardiac channels slowly, resuscitation may require prolonged CPR together with lipid emulsion while the drug redistributes, and the arrest can be resistant to defibrillation and epinephrine
ANSWER: E
Rationale:
The slow dissociation of bupivacaine from cardiac sodium channels means that even after successful electrical cardioversion the channels rapidly re-block, so the arrest is characteristically resistant to defibrillation and to epinephrine. Resuscitation may therefore require prolonged CPR — sometimes 30 to 60 minutes or longer — combined with lipid emulsion (and, in refractory cases, extracorporeal support) while the drug redistributes and is sequestered away from the heart.
Option A: Option A is incorrect because the slow-out kinetics specifically prevent instant reversal with a single shock.
Option B: Option B is incorrect because bupivacaine toxicity requires specific therapy (lipid emulsion) and often prolonged effort, not brief compressions alone.
Option C: Option C is incorrect because it misstates the kinetics; the drug leaves slowly, and standard short ACLS is frequently inadequate.
Option D: Option D is incorrect because slow dissociation makes toxicity more severe and persistent, not mild and self-correcting.
21. Given that the most common cause of LAST is accidental intravascular injection, and that epinephrine in the solution produces a detectable tachycardia if injected into a vessel, which injection technique best reduces the chance of delivering a full toxic dose intravascularly?
A) Fractionating the dose into small increments with aspiration between each, watching for a tachycardic response to the epinephrine marker, so intravascular placement is detected before the entire dose is given
B) Injecting the entire dose as a single rapid bolus to finish before any reaction can develop
C) Omitting epinephrine so there is no cardiovascular response to interpret
D) Using the largest possible volume of the most concentrated solution available
E) Skipping aspiration because it slows the procedure unnecessarily
ANSWER: A
Rationale:
Fractionating the injection — delivering the local anesthetic in small increments with aspiration before each, and pausing to watch for a tachycardic response to the epinephrine marker — allows intravascular placement to be detected before a full toxic dose has been delivered, and it exploits the time-dependent lung first-pass buffering. This directly addresses the leading cause of LAST.
Option B: Option B is incorrect because a single rapid bolus is exactly the dangerous maneuver that delivers a full toxic dose intravascularly before any warning.
Option C: Option C is incorrect because omitting epinephrine removes a useful intravascular marker and the absorption-slowing benefit.
Option D: Option D is incorrect because large volumes of concentrated solution increase, rather than reduce, the total dose at risk.
Option E: Option E is incorrect because aspiration is a key safety step, and skipping it removes an opportunity to detect a vessel before injecting.
22. A patient says she is "allergic to lidocaine" because at a dental visit she felt her heart racing and pounding and became anxious after the injection. Drawing on what earlier questions established about amide allergy and about epinephrine effects, what is the most likely explanation?
A) She has a confirmed true IgE-mediated allergy to the amide anesthetic and must never receive any local anesthetic again
B) She has methemoglobinemia and needs methylene blue before any future procedure
C) Her reaction most likely reflects the systemic effects of the epinephrine in the dental anesthetic (or anxiety/vasovagal response) rather than a true allergy, since true allergy to amides such as lidocaine is very rare
D) She is allergic to all amide and ester anesthetics equally and has no safe options
E) Her racing heart proves an anaphylactic reaction requiring lifelong avoidance of amides
ANSWER: C
Rationale:
Most reactions patients label "local anesthetic allergy" are not true immunologic allergy. A racing, pounding heart with anxiety after a dental injection is the classic picture of systemically absorbed epinephrine (frequently included in dental cartridges) or a vasovagal/anxiety response — not an IgE-mediated reaction. True allergy to amide agents such as lidocaine is very rare. Careful history distinguishes these, and the patient can usually receive amide anesthetics safely, with formal allergy evaluation reserved for genuinely ambiguous cases.
Option A: Option A is incorrect because the described symptoms are sympathomimetic, not the urticaria/angioedema/bronchospasm of true allergy, and lifelong avoidance is unwarranted.
Option B: Option B is incorrect because palpitations and anxiety are not the cyanosis-and-oxygen-resistant pattern of methemoglobinemia.
Option D: Option D is incorrect because there is no basis for assuming cross-class allergy; the history points away from any true allergy.
Option E: Option E is incorrect because tachycardia alone does not prove anaphylaxis, and the picture is far more consistent with epinephrine effect than with an allergic emergency.
This Web-based pharmacology and disease-based integrated teaching site is based on reference materials that are believed reliable and consistent with standards accepted at the time of development.
Possibility of error and on-going research and development in medical sciences do not allow assurance that the information contained herein is in every respect accurate or complete.
Users should confirm the information contained herein with other sources.
This site should only be considered as a teaching aid for undergraduate and graduate biomedical education and is intended only as a teaching site.
Information contained here should not be used for patient management and should not be used as a substitute for consultation with practicing medical professionals.
Users of this website should check the product information sheet included in the package of any drug they plan to administer to be certain that the information contained in this site is accurate and that changes have not been made in the recommended dose or in the contraindications for administration.
Medical or other information thus obtained should not be used as a substitute for consultation with practicing medical or scientific or other professionals.